Bausch + Lomb Corp
NYSE:BLCO

Watchlist Manager
Bausch + Lomb Corp Logo
Bausch + Lomb Corp
NYSE:BLCO
Watchlist
Price: 19.57 USD -1.21% Market Closed
Market Cap: 6.9B USD
Have any thoughts about
Bausch + Lomb Corp?
Write Note

Bausch + Lomb Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bausch + Lomb Corp
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Bausch + Lomb Corp
NYSE:BLCO
Revenue
$4.1B
CAGR 3-Years
7%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Ostrom Climate Solutions Inc
XTSX:COO
Revenue
CA$5.4m
CAGR 3-Years
19%
CAGR 5-Years
1%
CAGR 10-Years
-2%
No Stocks Found

Bausch + Lomb Corp
Revenue Breakdown

Breakdown by Geography
Bausch + Lomb Corp

Total Revenue: 4.1B USD
100%
United States And Puerto Rico: 1.9B USD
46.6%
Other: 655m USD
15.8%
China: 344m USD
8.3%
France: 210m USD
5.1%
Japan: 187m USD
4.5%
Germany: 147m USD
3.5%
United Kingdom: 121m USD
2.9%
Canada: 110m USD
2.7%
Russia: 106m USD
2.6%
Spain: 85m USD
2.1%
Italy: 82m USD
2%
Mexico: 68m USD
1.6%
Poland: 51m USD
1.2%
South Korea: 46m USD
1.1%
Show More
Show Less

Breakdown by Segments
Bausch + Lomb Corp

Total Revenue: 4.1B USD
100%
Product Sales: 4.1B USD
99.6%
Vision Care: 2.5B USD
61.3%
Devices: 1.7B USD
39.8%
Otc: 1.6B USD
38.9%
Surgical: 767m USD
18.5%
Pharmaceuticals: 618m USD
14.9%
Branded And Other Generics: 252m USD
6.1%
Other Revenues: 15m USD
0.4%
Show More
Show Less

Bausch + Lomb Corp
Glance View

Market Cap
6.9B USD
Industry
Health Care

Bausch + Lomb Corp., a subsidiary of Bausch Health Companies Inc., is a global leader in the eye health sector, dedicated to enhancing the vision and overall well-being of individuals worldwide. With a history spanning over 160 years, the company has built a robust portfolio that includes contact lenses, lens care products, and surgical devices. Their commitment to innovation is evident in their continuous investment in research and development, which has led to breakthrough technologies, such as advanced ocular surgical instruments and solutions that improve the quality of life for patients with vision impairments. As the global population ages and the demand for eye care products increases, Bausch + Lomb is well-positioned to capitalize on these trends, making it an appealing consideration for investors seeking growth in a stable, essential market. In addition to its innovative product offerings, Bausch + Lomb benefits from a strong brand reputation and a well-established distribution network, allowing it to reach millions of customers across diverse markets. The company's focus on expanding its market share through strategic partnerships and acquisitions adds a layer of potential for revenue growth. Investors should note that eye health is a critical aspect of healthcare, making Bausch + Lomb's mission not only significant but also potentially lucrative. As the company navigates the evolving landscape of the health and wellness industry, its strategic focus on eye care uniquely positions it as a reliable investment opportunity for those looking to strengthen their portfolios with a company that marries tradition with modernity in a timeless sector.

BLCO Intrinsic Value
26.53 USD
Undervaluation 26%
Intrinsic Value
Price

See Also

What is Bausch + Lomb Corp's Revenue?
Revenue
4.1B USD

Based on the financial report for Dec 31, 2023, Bausch + Lomb Corp's Revenue amounts to 4.1B USD.

What is Bausch + Lomb Corp's Revenue growth rate?
Revenue CAGR 5Y
2%

Over the last year, the Revenue growth was 10%. The average annual Revenue growth rates for Bausch + Lomb Corp have been 7% over the past three years , 2% over the past five years .

Back to Top